Nuvalent Inc vs Workiva Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Workiva Inc trades at $55.02 (market cap $3.21B). The key difference: Nuvalent Inc is far larger — about 3.1× Workiva Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Workiva Inc nearer its low. Which is the better fit depends on your goals.
| NUVL | WK | |
|---|---|---|
Market Cap | $9.81B | $3.21B |
Sector | Technology | Technology |
52-Week High | $123.96 | $93.31 |
52-Week Low | $72.16 | $44.31 |
Enterprise Value | $8.52B | $3.14B |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →